CNN CNN Newsroom June 4, 2024 15:43:00
Senior medical correspondent elizabeth cohen joins us now. how promising is this new drug? and given the side effects, is it worth it in terms of what researchers are saying at this point? >> bianna, essentially that's what the u.s. food & drug administration has to decide. they fasttracked this drug, but the study authors themselves say that longer studies need to be done. so efficacy, first, what they did, they took 1800 people between the ages of 50 and 90 who had mild early stages of alzheimer's. hat goff a ploo seo, hat the dripping. the half that got the drug did see a decline, but 27% s...
Source: archive.org